Successful CAR T Cell Therapy in a Heart and Kidney Transplant Recipient With Refractory PTLD

Daniel Oren; Ersilia M DeFilippis; Dor Lotan; Kevin J Clerkin; Justin Fried; Ran Reshef; Hilda Fernandez; Edward Lin; Jennifer Amengual; Gabriel Sayer; Nir Uriel; Jayant K Raikhelkar

doi:10.1016/j.jaccao.2022.09.002

Successful CAR T Cell Therapy in a Heart and Kidney Transplant Recipient With Refractory PTLD

JACC CardioOncol. 2022 Dec 20;4(5):713-716. doi: 10.1016/j.jaccao.2022.09.002. eCollection 2022 Dec.

Authors

Affiliations

¹ Division of Cardiology, Department of Medicine, NewYork-Presbyterian, Columbia University Irving Medical Center, New York, New York, USA.
² Blood and Marrow Transplantation and Cell Therapy Program, NewYork-Presbyterian, Columbia University Irving Medical Center, New York, New York, USA.
³ Division of Nephrology, Department of Medicine, NewYork-Presbyterian, Columbia University Irving Medical Center, New York, New York, USA.
⁴ Division of Hematology and Oncology, Herbert Irving Comprehensive Cancer Center, NewYork-Presbyterian, Columbia University Irving Medical Center, New York, NY, USA.

No abstract available

Keywords: CAR T cell; CAR, chimeric antigen receptor; CRS, cytokine release syndrome; EBV, Epstein-Barr virus; PTLD, post-transplant lymphoproliferative disorder; heart transplantation; immunotherapy; kidney transplantation; post-transplant lymphoproliferative disorder.

Publication types

Review

Publication types

Grants and funding